These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 6206838

  • 1. Control of coagulation and fibrinolysis by plasma proteinase inhibitors.
    Travis J, Salvesen G.
    Behring Inst Mitt; 1983 Aug; (73):56-65. PubMed ID: 6206838
    [Abstract] [Full Text] [Related]

  • 2. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M, Roem D, Kamp AM, de Boer JP, Hack CE, ten Cate JW.
    Thromb Haemost; 1993 Feb 01; 69(2):141-6. PubMed ID: 7681223
    [Abstract] [Full Text] [Related]

  • 3. Plasma proteinase inhibitors.
    Bodmer JL, Schnebli HP.
    Schweiz Med Wochenschr; 1984 Oct 06; 114(40):1359-63. PubMed ID: 6208604
    [Abstract] [Full Text] [Related]

  • 4. Natural inhibitors of the coagulation system.
    Messmore HL.
    Semin Thromb Hemost; 1982 Oct 06; 8(4):267-75. PubMed ID: 6184781
    [No Abstract] [Full Text] [Related]

  • 5. Changes in the contact system during orthotopic liver transplantation with and without aprotinin.
    Segal HC, Hunt BJ, Cottam S, Beard C, Francis JL, Potter D, Tan KC.
    Transplantation; 1995 Feb 15; 59(3):366-70. PubMed ID: 7532878
    [Abstract] [Full Text] [Related]

  • 6. Proteases and protease inhibitors in cerulein-induced acute pancreatitis in rats.
    Kruse P, Lasson A, Hage E.
    J Surg Res; 1999 Aug 15; 85(2):294-300. PubMed ID: 10423332
    [Abstract] [Full Text] [Related]

  • 7. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
    Derkx FH, Bouma BN, Schalekamp MA.
    J Lab Clin Med; 1984 Apr 15; 103(4):560-73. PubMed ID: 6366096
    [Abstract] [Full Text] [Related]

  • 8. Proteolytic enzymes and catabolism: enhanced release of granulocyte proteinases in uremic intoxication and during hemodialysis.
    Heidland A, Hörl WH, Heller N, Heine H, Neumann S, Heidbreder E.
    Kidney Int Suppl; 1983 Dec 15; 16():S27-36. PubMed ID: 6376917
    [Abstract] [Full Text] [Related]

  • 9. Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors.
    Walker JB, Bajzar L.
    J Thromb Haemost; 2007 Jun 15; 5(6):1257-64. PubMed ID: 17389009
    [Abstract] [Full Text] [Related]

  • 10. Isolation of nine human plasma proteinase inhibitors by sequential affinity chromatography.
    Dubin A, Potempa J, Travis J.
    Prep Biochem; 1990 Jun 15; 20(1):63-74. PubMed ID: 1694995
    [Abstract] [Full Text] [Related]

  • 11. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S.
    Dan Med Bull; 1993 Sep 15; 40(4):383-408. PubMed ID: 8222763
    [Abstract] [Full Text] [Related]

  • 12. Elastosis in breast carcinoma: II. Association of protease inhibitors with immature elastic fibres.
    Davies JD, Mera SL.
    J Pathol; 1987 Dec 15; 153(4):317-24. PubMed ID: 2448440
    [Abstract] [Full Text] [Related]

  • 13. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
    Wachtfogel YT, Kucich U, Hack CE, Gluszko P, Niewiarowski S, Colman RW, Edmunds LH.
    J Thorac Cardiovasc Surg; 1993 Jul 15; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
    [Abstract] [Full Text] [Related]

  • 14. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
    Nielsen VG.
    Blood Coagul Fibrinolysis; 2007 Oct 15; 18(7):647-56. PubMed ID: 17890952
    [Abstract] [Full Text] [Related]

  • 15. Effect of anabolic steroids on plasma antithrombin III. alpha2 macroglobulin and alpha1 antitrypsin levels.
    Walker ID, Davidson JF, Young P, Conkie JA.
    Thromb Diath Haemorrh; 1975 Sep 30; 34(1):106-14. PubMed ID: 52896
    [Abstract] [Full Text] [Related]

  • 16. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND, Gonzales EC, Shayestehfar B, Barton CH.
    J Lab Clin Med; 1994 Jul 30; 124(1):118-24. PubMed ID: 7518491
    [Abstract] [Full Text] [Related]

  • 17. Plasma inhibitors of the Hageman factor dependent pathways.
    Schreiber AD.
    Semin Thromb Hemost; 1976 Jul 30; 3(1):32-51. PubMed ID: 799348
    [Abstract] [Full Text] [Related]

  • 18. The functional role of acute phase plasma proteinase inhibitors.
    Travis J, Shieh BH, Potempa J.
    Tokai J Exp Clin Med; 1988 Dec 30; 13(6):313-20. PubMed ID: 3152555
    [Abstract] [Full Text] [Related]

  • 19. Coagulation and fibrinolytic reactions in experimental porcine septic shock: pretreatment with different antiplatelet factors.
    Svartholm E, Bergqvist D, Haglund U, Ljungberg J, Hedner U.
    Circ Shock; 1987 Dec 30; 22(4):291-301. PubMed ID: 2443265
    [Abstract] [Full Text] [Related]

  • 20. 15 parameters of coagulation and fibrinolysis in children with type I diabetes mellitus (onset period).
    Koert M, Nowak-Göttl U, Kreuz W, Grüttner HP, Kornhuber B, Breddin HK.
    Klin Padiatr; 1991 Dec 30; 203(6):429-32. PubMed ID: 1721940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.